RE:RE:And it seems like the markets don’t really care The lawsuit is not contesting GW's right to manufacture and distribute their products abroad. It's only challenging products distributed within the Domestic US since that's where Canopy's patent protection applies.
I understand the broader context for how they can use this against competitors within the US, however patent trolling is fun if the person you're doing it to is smaller than you. GW Pharma was just scooped up by Jazz who are an actual Pharma co with real money and real lawyers.
This is what I mean by slamming your d*ck in a drawer. Canopy is not in a financial position for a drawn out patent battle, especially over a method with questionable origin claims like CO2. GW may also not have been, but Jazz definitely is. If Jazz chooses to challege the claim they can end up either destroying Canopy's patent or litigating them into submission.
Yes this is a testament to the importance of patent protection in the Cannabis space but color me impressed that Canopy would find a new black hole of money by going after GW instead of testing the smaller MSO's first.